Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep 24;10(1):15585.
doi: 10.1038/s41598-020-72323-w.

Effect of fasting and feeding on apolipoprotein A-I kinetics in preβ1-HDL, α-HDL, and triglyceride-rich lipoproteins

Maud Chétiveaux  1 , Mikaël Croyal  2   3 , Khadija Ouguerram  1   4 , Fanta Fall  1 , Laurent Flet  5 , Yassine Zair  1 , Estelle Nobecourt  1   6 , Michel Krempf  1   7
Affiliations

Effect of fasting and feeding on apolipoprotein A-I kinetics in preβ1-HDL, α-HDL, and triglyceride-rich lipoproteins

Maud Chétiveaux et al. Sci Rep. .

Abstract

The aim of this study was to compare the kinetics of apolipoprotein (apo)A-I during fed and fasted states in humans, and to determine to what extent the intestine contributes to apoA-I production. A stable isotope study was conducted to determine the kinetics of apoA-I in preβ1 high-density lipoprotein (HDL) and α-HDL. Six healthy male subjects received a constant intravenous infusion of 2H3-leucine for 14 h. Subjects in the fed group also received small hourly meals. Blood samples were collected hourly during tracer infusion and then daily for 4 days. Tracer enrichments were measured by mass spectrometry and then fitted to a compartmental model using asymptotic plateau of very-low-density lipoprotein (VLDL) apoB100 and triglyceride-rich lipoprotein (TRL) apoB48 as estimates of hepatic and intestinal precursor pools, respectively. The clearance rate of preβ1-HDL-apoA-I was lower in fed individuals compared with fasted subjects (p < 0.05). No other differences in apoA-I production or clearance rates were observed between the groups. No significant correlation was observed between plasma apoC-III concentrations and apoA-I kinetic data. In contrast, HDL-apoC-III was inversely correlated with the conversion of α-HDL to preβ1-HDL. Total apoA-I synthesis was not significantly increased in fed subjects. Hepatic production was not significantly different between the fed group (17.17 ± 2.75 mg/kg/day) and the fasted group (18.67 ± 1.69 mg/kg/day). Increase in intestinal apoA-I secretion in fed subjects was 2.20 ± 0.61 mg/kg/day. The HDL-apoA-I kinetics were similar in the fasted and fed groups, with 13% of the total apoA-I originating from the intestine with feeding.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Evolution of main lipid parameters during the kinetic protocols. The white circles indicate the fasted sate and the grey circles indicate the feeding state. Values represent means ± SD for six subjects. *p < 0.05; **p < 0.01 (Wilcoxon matched-pairs signed rank test).
Figure 2
Figure 2
Enrichment of plasma leucine (A), VLDL-apoB100 (B), preβ1-HDL-apoA-I (C) and α-HDL-apoA-I (D) with deuterated leucine during the fasted (white circles) and fed state (grey circles) over 14 h or 96 h. Values represent means ± SD for six subjects.
Figure 3
Figure 3
Enrichment of TRL-apoB48 with deuterated leucine during the fed state. Values represent means ± SD for six subjects.
Figure 4
Figure 4
ApoA-I tracer/tracee ratios within TRL, preβ1-HDL and α-HDL fractions after a constant deuterated leucine infusion in a representative subject in a fed state.
Figure 5
Figure 5
Multi-compartmental model used to analyze kinetics of apolipoprotein A-I (apoA-I) in the fasting (A) and the fed (B) states.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Hegele RA, et al. Rare dyslipidaemias, from phenotype to genotype to management: A European Atherosclerosis Society task force consensus statement. Lancet Diabetes Endocrinol. 2020;8:50–67. doi: 10.1016/S2213-8587(19)30264-5. - DOI - PubMed
    1. Rye K-A, Barter PJ. Formation and metabolism of prebeta-migrating, lipid-poor apolipoprotein A-I. Arterioscler. Thromb. Vasc. Biol. 2004;24:421–428. doi: 10.1161/01.ATV.0000104029.74961.f5. - DOI - PubMed
    1. Cohn JS, Wagner DA, Cohn SD, Millar JS, Schaefer EJ. Measurement of very low density and low density lipoprotein apolipoprotein (Apo) B-100 and high density lipoprotein Apo A-I production in human subjects using deuterated leucine. Effect of fasting and feeding. J. Clin. Investig. 1990;85:804–811. doi: 10.1172/JCI114507. - DOI - PMC - PubMed
    1. Rye KA, Clay MA, Barter PJ. Remodelling of high density lipoproteins by plasma factors. Atherosclerosis. 1999;145:227–238. doi: 10.1016/S0021-9150(99)00150-1. - DOI - PubMed
    1. Danielsen EM, Hansen GH, Poulsen MD. Apical secretion of apolipoproteins from enterocytes. J. Cell Biol. 1993;120:1347–1356. doi: 10.1083/jcb.120.6.1347. - DOI - PMC - PubMed

Publication types